We’ve been asked by CADTH* to do a Patient Group Review of the new INTERFERON-FREE drug combo sofosbuvir and ledipasvir (also known as SOVALDI and GS-5885) for Chronic Hepatitis C, developed by Gilead Sciences. We urgently request input from individual HCV+ people (both those who have and have not tried this drug combination, any genotype).

*CADTH = Canadian Agency for Drugs and Technologies in Health, which does government-requested reviews for Health Canada and the Canadian Drug Review process.